Skip to main content

Table 5 PET-CT features of patients with pulmonary hamartoma

From: Diagnosis value of 18F-Fluoro-d-glucose positron emission tomography-computed tomography in pulmonary hamartoma: a retrospective study and systematic review

Patients (literature)

Whether the lesion had high FDG uptake

Whether the lymph node had high FDG uptake

Whether other parts of the body had high FDG uptake

PET-CT diagnosis

Combined with other tumor or inflammation

1

No

No

No

Benign

Myoma of uterus

2

No

No

No

Malignant

No

3

No

No

No

Benign

No

4

No

No

Rectum wall

Benign

No

5

No

Right hilar lymph nodes

No

Benign

Mechanized pneumonia in RUL

6

No

No

No

Benign

No

7

No

Left submandibular lymph node

Nasal pharynx

Benign

No

8

No

Left submandibular lymph node

Nasal pharynx,

Benign

No

9

No

No

No

Benign

No

10

No

No

Cervix uteri

Malignant

Cervical cancer

11

No

No

No

Benign

No

12

No

No

No

Benign

Myoma of uterus

13

No

No

No

Malignant

No

14

No

No

Tumor in LLL

Malignant

Pulmonary melanoma in LLL

15

No

No

Tumor in RUL

Malignant

Lung cancer in RUL

16

No

No

No

Benign

No

17

No

No

SPN in RML, RLL. Nasal pharynx

Benign

Inflammation lesion in RML, RLL

18

No

Left cervical lymph node,

Right breast, BSO, left shoulder blade

Benign

Lung cancer in RLL

19

No

Submandibular lymph node

No

Benign

No

20

No

NA

NA

Malignant

No

21 [15]

No

No

No

Malignant

No

22 [16]

SUVmax:2.6

No

No

Malignant

No

23 [17]

SUVmax:3.0

NA

NA

Malignant

No

24 [3]

No

NA

NA

Malignant

No

25 [4]

No

No

Left upper femur

Malignant

No

  1. LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right medium lobe; RUL, right upper lobe; NA: not available; SPN: small Solitary Pulmonary Nodule; PH: pulmonary hamartoma; BSO, bilterl slpingooophorectomy